Method for predicting the onset of extrapyramidal symptoms (EPS) induced by an antipsychotic-based treatment
An antipsychotic, extrapyramidal technology, used in biochemical devices and methods, drug combinations, neurological diseases, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0135] Materials and methods
[0136] subjects
[0137] Sample size calculations assumed a 5% significance level, 80% power and an EPS risk (odds ratio) of 2 associated with carrying the studied allele (allele frequency >0.1). Quanto1.2 software (http: / / hydra.usc.edu / gxe) was used for calculation.
[0138] During a three-year period (2002-2004), a cohort of 321 inpatient psychiatric patients receiving antipsychotic drug therapy was sequentially recruited at the Psychiatry Service of the Hospital Clínic (Barcelona, Spain). 241 subjects from this cohort participated in the pharmacogenetic study of EPS presented here. Subjects diagnosed according to DSM-IV criteria: 184 subjects diagnosed with schizophrenia (n=125) and related disorders (n=22 schizoaffective disorder; n=27 acute psychotic disorder; n=9 delusions psychotic disorder; n=1 schizoid personality disorder); 40 were diagnosed with bipolar disorder; and 17 had other diagnoses (including personality disorder, psycho...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
